THE MINISTRY OF HEALTH THE SOCIALIST REPUBLIC OF VIETNAM ------Independence - Freedom - Happiness ------

No. 09/2015/TT-BYT Hanoi, May 25, 2015

CIRCULAR STIPULATING THE APPROVAL FOR CONTENTS OF ADVERTISEMENTS FOR SPECIAL PRODUCTS, COMMODITIES AND SERVICES UNDER THE AUTHORITY OF THE MINISTRY OF HEALTH Pursuant to the Law on Advertising dated June 21, 2012; Pursuant to the Law on Food Safety dated June 17, 2010; Pursuant to the Law on Medical Examination and Treatment dated November 23, 2009; Pursuant to the Law on Chemicals dated November 21, 2007; Pursuant to the Law on Pharmacy dated June 14, 2005; Pursuant to the Government’s Decree No. 181/2013/NĐ-CP dated November 14, 2013 on providing specific provisions on implementation of several articles of the Law on Advertising; Pursuant to the Government’s Decree No. 100/2014/NĐ-CP dated November 6, 2014 on providing regulations on trading and consumption of infant nutritional products, feeding bottles and artificial nipples; Pursuant to the Government’s Decree No. 63/2012/NĐ-CP dated August 31, 2012 on defining the functions, tasks, powers and organizational structure of the Ministry of Health; After considering the request of the Director of the Department of Legal Affairs; The Minister of Health hereby promulgates the Circular on the approval for contents of advertisements for special products, commodities and services under the authority of the Ministry of Health. Chapter I GENERAL PROVISIONS Article 1. Scope of application This Circular stipulates requirements, authority to decide, necessary documentation submitted to apply for and procedures for approval for contents of advertisements for special products, commodities and services under the authority of the Ministry of Health which include: 1. Pharmaceutical products which are not prohibited from being advertised as stipulated in Clause 5 Article 7 of the Law on Advertising. 2. Cosmetic products. 3. Food, food additives under the delegated authority of the Ministry of Health, including: a) Functional foods b) Micronutrient-fortified foods c) Natural mineral water; d) Bottled drinking water; dd) Food additives or food processing aids 4. Chemicals, pesticide products, disinfectants or sanitizers used in household appliance and health care industry. 5. Medical equipment. 6. Baby milk and nutritional products under the authority of the Ministry of Health which are not subject to the advertising ban stipulated in Clause 1 Article 7 of the Law on Advertising. 7. Health care services. Article 2. Applicable entities This Circular shall apply to organizations or individuals engaged in approval for contents of advertisements for special products, commodities and services under the authority of the Ministry of Health throughout Vietnam. Article 3. Examination cost, fee for issuance and reissuance of the written approval for contents of advertisements for special products, commodities and services under the authority of the Ministry of Health 1. The applicant for approval for advertisement contents shall be liable for the examination cost, fee for issuance or reissuance of advertisement contents at the competent authority that receives the application for advertisement contents in accordance with laws. 2. While filing an application for approval for the content of an advertisement, advertisement examination cost and approval fee must be paid as follows: a) The followings shall be considered as one application for approval for advertisement contents, including: - An advertisement for a product, commodity or service that target a particular group of customers; - An advertisement for a product, commodity or service that targets a particular group of customers and takes different advertisement forms such as fliers, banners, books or newspapers, etc. b) The followings shall not be considered as one application for approval for advertisement contents, including: - Different advertisements for a product, commodity or service that target a particular group of customers. In this case, each advertisement shall be considered as an application for approval for advertisement contents; - An advertisement conveying a product, commodity or service to a particular group of customers. In this case, each product, commodity or service shall be considered as an application for approval for advertisement contents; c) Advertising of pharmaceutical products: The followings shall be considered as one application for approval for pharmaceutical advertisement contents, including: - Cases governed by regulations laid down in Point a Clause 2 of this Article; - An advertisement for a pharmaceutical product with one content or one dosage form that target a particular group of customers; - An advertisement for two or multiple pharmaceutical products with the same active ingredient, and different contents, dosage forms or administration which are produced by the same manufacturer and target a particular group of customers. d) Advertising of cosmetic products: a) The followings shall be considered as one application for approval for cosmetic advertisement contents, including: - Cases governed by regulations laid down in Point a Clause 2 of this Article; - One advertisement for two or multiple products together with one notification of the cosmetic products with the receiving number dd) Food or food additives: - The followings shall be considered as one application for approval for food or food additive advertisement contents, including: + Cases governed by regulations laid down in Point a Clause 2 of this Article; + An advertisement for two or multiple food or food additive products which have the same effect and target a particular group of customers. - The followings shall be considered as one application for approval for food or food additive advertisement contents, including: + Cases governed by regulations laid down in Point b Clause 2 of this Article; + An advertisement for two or multiple food or food additive products which have the same effects and target different groups of customers. In this case, each product shall be considered as an application for approval for advertisement contents. Chapter II REQUIREMENTS, AUTHORITY TO DECIDE, NECESSARY DOCUMENTATION SUBMITTED TO APPLY FOR AND PROCEDURES FOR APPROVAL FOR CONTENTS OF ADVERTISEMENTS FOR SPECIAL PRODUCTS, COMMODITIES AND SERVICES UNDER THE AUTHORITY OF THE MINISTRY OF HEALTH Article 4. General requirements for grant of approval for an advertisement content 1. The advertisement content must conform to legal regulations on advertising and none of prohibited acts stipulated in Article 8 of the Law on Advertising is committed. 2. Voices, wording and pictures used in an advertisement must be concise, common and conform to regulations laid down in Article 18 of the Law on Advertising. The smallest size of the font used in an advertisement content must be large enough to be read in a normal condition and is not smaller than the size proportional to the size of Vntime font or the 12-point size of Times New Roman font printed on the A4-size paper. Article 5. Requirements for grant of approval for a pharmaceutical advertisement content Pharmaceutical products must meet requirements for being advertised as stipulated in Point a Clause 4 Article 20 of the Law on Advertising, and conform to the regulations laid down in Article 3 of the Government's Decree No. 181/2013/NĐ-CP on providing specific regulations on implementation of several articles of the Law on Advertising (hereinafter referred to as the Decree No. 181/2013/NĐ-CP) as well as the following specific provisions: 1. Pharmaceutical products permitted to be advertised in accordance with Clause 1 Article 1 hereof shall include: a) Pharmaceutical products specified in the list of over-the-counter medicines and not subject to the competent authority’s warning of restricted use or permitted use under the doctor’s medical supervision; b) With regard to advertising of pharmaceutical products through audio and video news, such products must contain main active ingredients in the list of medicinal active ingredients and herbal materials permitted to be advertised through audio and video news as stipulated in the Appendix No. 02 enclosed herewith. 2. Pharmaceutical products have been accredited by numerical codes of free circulation in Vietnam which remain valid and instructional leaflets which have been approved by the Ministry of Health. 3. All necessary documents must be submitted as stipulated in Article 14 hereof. 4. The applicant for approval for advertisement contents is the organization that signs its name on the registration certificate of free circulation for products, or the Vietnam representative office of the organization that signs its name on the registration certificate of free circulation for products, or the organization with its legal standing authorized in writing by the organization that signs its name on the registration certificate of free circulation for products. 5. Contents of advertisements for pharmaceutical products must conform to the following regulations: a) Be consistent with documents stipulated in Clause 1 Article 3 of the Decree No. 181/2013/NĐ-CP; b) Provide sufficient information stipulated in Clause 2 Article 3 of the Decree No. 181/2013/NĐ-CP and the following information: - When advertising pharmaceutical products on books, newspapers, magazines and flyers, the information such as precautions, dosage and administration must be included; - As for advertising of pharmaceutical products on audio and video news, the contents defined in Clause 3 Article 3 of the Decree No. 181/2013/NĐ-CP, indications, contraindication or warnings to special users, must be clear in order for audiences to hear or read in a sufficient and explicit manner; - Advertisements aired on online newspapers, electronic information pages and advertising screens: + Sound advertisement contents must include information pieces which are the same as advertisements aired on audio and video news; + Non-sound advertisement contents must include information pieces which are the same as advertisements aired on books, newspapers, magazines and flyers; If there are many advertising pages/shots, these pages/shot should be in steady motion, or paused deliberately in order for viewers to read all information conveyed on that page; pages or shots displaying product information should be unanimated without any movement in order for viewers to carefully read such information. c) Pharmaceutical advertisement contents by means of outdoor means must include all necessary information stipulated in Clause 4 Article 3 of the Decree No. 181/2013/NĐ-CP. d) Indications prevented from being included in a pharmaceutical advertisement content shall comprise: - Indications stipulated in Clause 5 Article 3 of the Decree No. 181/2013/NĐ-CP; - Indications of curing viral hepatitis and strange diseases currently emerging. dd) Information or images banned for use in the pharmaceutical advertising shall include: - Information or images stipulated in Clause 6 Article 3 of the Decree No. 181/2013/NĐ-CP; - Overstatement of pathological conditions or effects of a pharmaceutical product; - Images of animals or plants defined in the list of protected animals or plants; - Information, images likely to make consumers believe that consultation with doctors before using the pharmaceutical product is not important; the pharmaceutical product is absolutely harmless to consumers; there is none of side effects or contraindications; and the pharmaceutical product is 100% effective . Article 6. Requirements for grant of approval for a cosmetic advertisement content 1. Cosmetic products must conform to advertisement requirements stipulated in Point b Clause 4 Article 20 of the Law on Advertising. 2. Cosmetic advertisement contents must conform to regulations laid down in Article 4 of the Decree No. 181/2013/NĐ-CP and the followings: a) Do not use images, costumes, names, mails and articles of other organizations, healthcare establishments, doctors, pharmacists or medical staff; b) Features and effects of a cosmetic product must accord with its nature, classification as well as those that have been already made known to the public in accordance with legal regulations. 3. All necessary documents must be submitted as stipulated in Article 15 hereof. 4. The applicant for approval for advertisement contents is the organization that signs its name on the product notification, or the representative office of that organization, or the organization with its legal standing authorized in writing by that organization. Article 7. Requirements for grant of approval for a food, food additive advertisement content 1. Food or food additive products endorsed by the certificate of declaration of conformity to food safety regulations (applicable to products that have not been governed by National technical regulations) or certificate of declaration of conformity issued by the competent regulatory authorities. 2. Advertisement contents must conform to regulations laid down in Article 5 of the Decree No. 181/2013/NĐ- CP and the followings: a) As for advertisement contents other than those that have been already announced, legal documents, scientific studies that support these contents must be submitted while reference sources must be specified in the mockup or script of an advertisement; as for products with special use and storage, these must be presented in an advertisement; b) An advertisement displayed on signboards, signs, banners, racks, shelves, or in the form of texts running at the bottom of the screen in a television program, imprinted on other items, or objects in the air, under the water, or movable objects, shall not be required to contain all information about how to use the product, effects, storage but shall be required to be consistent with the contents regulated by declaration of conformity or declaration of compliance with food safety regulations; c) Do not advertise food products in the form of an article composed by a doctor, pharmacist, medical staff, and mention the content which may describe the effect of such products on disease treatment; d) Prohibit using images, costumes, names or mails of organizations, healthcare establishments, doctors, pharmacists, medical staff and testimonials of patients to serve the purpose of advertising food products. 3. All necessary documents must be submitted as stipulated in Article 16 hereof. 4. Applicants for approval for advertisement contents are those who sign their names on the Certificate of Declaration of conformity or Certificate of Declaration of conformity with the food safety regulations (applicable to products on which the National technical regulations has not been set yet), or have their legal standing to be authorized in writing by the legal holder of Certificate of Declaration of conformity and Certificate of Declaration of conformity with the food safety regulations. Article 8. Requirements for approval for contents of advertisements for chemicals, insecticides, disinfectants or sanitizers used in household appliance and health care industry. 1. All advertisement requirements stipulated in Point c Clause 4 Article 20 of the Law on Advertising must be met. 2. Advertisement contents must conform to regulations laid down in Article 6 of the Decree No. 181/2013/NĐ- CP. 3. All necessary documents must be submitted as stipulated in Article 17 hereof. 4. The applicant for approval for advertisement contents is the organization that signs its name on the registration certificate of free circulation for products, or the organization that has its legal standing to be authorized in writing by the legal holder of the registration certificate of free circulation for products. Article 9. Requirements for grant of approval for contents of advertisements for medical equipment 1. All advertisement requirements stipulated in Point g Clause 4 Article 20 of the Law on Advertising must be met. 2. Advertisement contents must conform to regulations laid down in Article 7 of the Decree No. 181/2013/NĐ- CP. 3. All necessary documents must be submitted as stipulated in Article 18 hereof. 4. The applicant for approval for advertisement contents is the organization that signs its name on the registration certificate of free circulation for products in respect of products manufactured in Vietnam or the import license in respect of imported products, or the Vietnam representative office of the organization that signs its name on the import license, or the organization with its legal standing authorized in writing by the organization that signs its name on the certificate of product circulation for products manufactured in Vietnam or the import license for imported products. Article 10. Requirements for approval for contents of advertisements for baby milk and nutritional products 1. All advertisement requirements stipulated in Point d Clause 4 Article 20 of the Law on Advertising must be met, and these products must be endorsed by Certificate of Declaration of conformity or Certificate of Declaration of conformity with the food safety regulations (applicable to products on which the technical regulations have not been set yet) issued by regulatory authorities. 2. Advertisement contents must conform to regulations laid down in Article 8 of the Government’s Decree 181/2013/NĐ-CP and Clause 2 Article 6 of the Government’s Decree No. 100/2014/NĐ-CP dated November 6, 2014 on providing regulations on trading and consumption of infant nutritional products, feeding bottles and artificial nipples. 3. All necessary documents must be submitted as stipulated in Article 16 hereof. 4. Applicants for approval for advertisement contents are those who sign their names on the Certificate of Declaration of conformity or Certificate of Declaration of conformity with the food safety regulations (applicable to products on which the National technical regulations has not been set yet), or those who have their legal standing to be authorized in writing by the legal holder of Certificate of Declaration of conformity and Certificate of Declaration of conformity with the food safety regulations. Article 11. Requirements for approval for contents of advertisements for health care services 1. All advertisement requirements stipulated in Point e Clause 4 Article 20 of the Law on Advertising must be met as follows: a) The license for medical operations, applicable to healthcare establishments; b) The certificate of medical practice, applicable to those required to achieve the practicing certificate by laws before being allowed to practise medical services. 2. Advertisement contents must conform to regulations laid down in Article 9 of the Decree No. 181/2013/NĐ- CP. 3. All necessary documents must be submitted as stipulated in Article 19 hereof. 4. Applicants for approval for advertisement contents are those who sign their names on the licence for medical operations, or those who have the legal standing to be authorized in writing by the legal holder of the license for medical operations. Article 12. Authority to issue the certificate of approval for advertisement contents that fall within the remit of the Ministry of Health 1. Organizations affiliated to the Ministry of Health shall have authority to issue the Certificate of approval for advertisement contents: a) Drug administration of Vietnam shall issue the certificate of approval for advertisement contents for pharmaceutical products as stipulated in Clause 1 Article 1 hereof; b) Vietnam Food Administration shall issue the Certificate of approval for advertisement contents for functional food; micronutrient-fortified food; baby milk and nutritional products as stipulated in Clause 6 Article 1 hereof; c) Medical Examination and Treatment Administration shall issue the Certificate of approval for advertisement contents for medical examination and treatment by employing modern medicinal practices released by healthcare establishments of which operations are licensed, and the list of professional practices is approved by the Minister of Health; d) Traditional Medicine Administration of Vietnam shall issue the Certificate of approval for advertisement contents for medical examination and treatment by employing traditional medicinal practices released by healthcare establishments of which operations are licensed, and the list of professional practices is approved by the Minister of Health; dd) Health Environment Management Agency shall issue the Certificate of approval for contents of advertisements for chemicals, insecticides, disinfectants or sanitizers used in household appliance and health care industry; e) Medical Equipment and Facilities Administration shall issue the Certificate of approval for advertisement contents for medical equipment and facilities (acting on behalf of the Minister of Health to sign). 2. The Department of Health in a centrally-affiliated city or province shall issue the Certificate of approval for advertisement contents for: a) Cosmetic products of the organization that signs their name on the notification of cosmetic products with their head office located within the remit of the Department of Health; If cosmetic products are advertised through conferences, seminars or events, the Department of Health in a centrally-affiliated city or province which is the proposed venue for these activities shall issue the Certificate of approval for advertisement contents; b) Medical examination or treatment services provided by healthcare establishments of which operations are licensed and the list of professional practices are approved by the Director of the Department of Health. 3. The Food Safety and Hygiene Subdepartment affiliated to the Department of Health in a centrally-affiliated city or province shall have authority to: a) Issue the Certificate of approval for advertisement contents for mineral water, bottled water, food additives, food processing aids; b) Issue the Certificate of approval for advertisement contents for forms of advertising through conferences, seminars and events for promotion of food and food additive products as stipulated in Clause 3 Article 1 hereof which are organized in the areas that fall within their remit; c) Give their opinions on advertisement contents for food products with the announcement of health effects when regulatory authorities assigned to issue the certificate or verify advertisement contents for food products under the authority of The Ministry of Industry and Trade and the Ministry of Agriculture and Rural Development carry out opinion polls. Article 13. General requirements for application for approval for contents of advertisements for products, commodities or services under the authority of the Ministry of Health 1. The application shall include 01 set of documents. 2. Each application shall include the following documents: a) Application form for approval for advertisement contents in accordance with regulations laid down in the Appendix 01 enclosed herewith; b) The Certificate of Business Registration of an enterprise or the license for representative office establishment of a foreign dealer; c) Contents of applications for approval for advertisements: - If these are advertised on audio and video news, the applicant is required to prepare 01 recording of proposed advertisement content written in VCDs, CDs or in the form of soft copies together with 03 copies of proposed advertising scripts in which contents, proposed advertisement instruments, pictorial (applicable to video news), oral and music contents, must be clearly described; - If these are advertised on the advertising means distinct from audio and video news, the applicant is obliged to prepare 03 copies of mockups of proposed advertisement contents printed in color in combination with soft copies recording the proposed advertisement contents; - If these are advertised through conferences, seminars or events: In addition to materials stipulated in this point, the applicant is required to submit the followings: the valid sample of advertisement contents used in the program approved by competent authorities (applicable to advertisements of which contents have been approved), agenda in which the presentation title and time (dd/mm/yy), venue (specific address); presentation contents, materials and handouts; name tags including academic ranks and professional qualifications of presenters (presenters must hold qualifications or degrees appropriate to products, commodities and services to be advertised. Advertising of pharmaceutical products: Presenters must hold professional qualifications in pharmacy. Advertising of healthcare services: Presenters must hold professional qualifications in medicine. Advertising of foods, food additives and food processing aids: Presenters must hold professional qualifications in medicine and pharmacy or other university degree or higher degree in relevant disciplines. d) Sample labels of these products or those approved by competent healthcare authorities, applicable to the case in which the law stipulates that product labels must be approved by competent healthcare authorities. 3. Other requirements imposed on applications: a) If the authorized applicant is filing the application for approval for advertisement contents, the following documents must be shown: - Legal authorization letter; - The Certificate of business registration or the license for representative office establishment of a foreign dealer held by the authorized applicant. b) Materials used for reference, demonstration and verification of information provided in the advertisement content: - English materials must be translated into Vietnamese, enclosing the original English ones. Translated materials in Vietnamese must be sealed by the applicant for approval for advertisement contents; - Materials in foreign languages other than English must be translated into Vietnamese, enclosing the original copies of these materials. Materials translated into Vietnamese must be notarized in accordance with legal regulations. c) Materials included in the application must be high-quality printouts which are arranged to follow procedures stipulated in articles hereof. Colorful pages are placed in between to separate different parts, and the cover page and list of materials are required as well; d) Documents included in the application for approval for advertisement contents must remain valid, or must be the authenticated duplicate or sealed duplicate of the applicant for approval for advertisement contents. All materials attached must be validated by stamp or edge stamp of the applicant for approval for advertisement contents; dd) Sample advertisements should be displayed on the A4-size paper. Sample large-size outdoor advertisement should be displayed on the A3-size paper or the paper in other size, and the ratio of the sample advertisement to the real one must be specified. 4. Requirements imposed on applications submitted to the provider of level-4 online public services: Applications shall be converted into soft files (01 copy) and governed under the direction of the provider of level-4 online public services Article 14. Application for approval for a pharmaceutical advertisement content 1. Documents stipulated in Article 13 hereof. 2. User’s instruction leaflets approved by the Drug Administration of Vietnam – the Ministry of Health. 3. Permit for product free circulation issued by the Drug administration of Vietnam or the decision on issuance of pharmaceutical registration numbers at the Drug Administration of Vietnam. Article 15. Application for approval for a cosmetic advertisement content 1. Documents stipulated in Article 13 hereof. 2. Notification of cosmetic products issued by competent authorities. 3. Valid and authoritative materials that demonstrate features and useful effects of these cosmetic products. This will happen if the advertisement content provides information about features or useful effects of these products but such information are not included in the notification of cosmetic products of which the receiving numbers have been issued by competent authorities. Article 16. Application for approval for advertisement contents for foods, food additives, baby milk and nutritional products 1. Documents stipulated in Article 13 hereof. 2. The Certificate of Declaration of conformity or Certificate of Declaration of conformity with the food safety regulations (applicable to products on which the technical regulations have not been set yet) issued by regulatory authorities. 3. Description of details about products which have been verified by competent authorities. 4. Valid and authoritative materials that demonstrate features, useful effects and particulars of these products. This will apply if the advertisement content provides information about features, useful effects and particulars of these products but such information are not included in the description of details about products verified by competent authorities. Article 17. Requirements for approval for contents of advertisements for chemicals, insecticides, disinfectants or sanitizers used in household appliance and health care industry. 1. Documents stipulated in Article 13 hereof. 2. The registration Certificate of free circulation for chemicals, insecticides, disinfectants or sanitizers. Article 18. Application for approval for contents of advertisements for medical equipment 1. Documents stipulated in Article 13 hereof. 2. The permit for import of medical equipment or the registration certificate of free circulation for medical equipment. Article 19. Application for approval for contents of advertisements for health care services 1. Documents stipulated in Article 13 hereof. 2. The permit for advertising of healthcare services granted by the Minister of Health or the Director of the Department of Health to healthcare establishments, and the professional practices approved by the Minister of Health or the Director of the Department of Health. 3. The Certificate of healthcare practicing held by the medical practitioner licensed to advertise their services. This will apply if the law stipulates that the practice certificate is compulsory. Article 20. Procedure for grant of the certificate of approval for advertisement contents 1. The applicant for approval for advertisement contents shall submit the application to the competent authority as stipulated in Article 12 hereof (hereinafter referred to as the receiving authority). 2. If the application is not valid, within a permitted period of 05 working days from receipt of such application based on the date stamp affixed to incoming documents at the receiving authority, the receiving authority shall send a request to the applicant for correction or improvement of this application. The maximum period allowed for the applicant to correct or improve their application is 90 days from receipt of the written notification from the receiving authority. After this period, the application for approval for advertisement contents shall be annulled. 3. Within 10 working days from receipt of all necessary documents based on the date stamp affixed to incoming documents, the competent authority shall issue the Certificate of approval for advertisement content by completing the form recommended in the Appendix 03 enclosed herewith. In case of refusing to issue the Certificate of approval for advertisement contents, the competent authority shall respond to the applicant to clearly state the reasons for such refusal. 4. The receiving authority shall be responsible for posting the list of products, commodities and services within their jurisdiction for which the certificate of approval for advertisement contents have been issued, or the certificate of approval for advertisement contents ends its validity on their electronic information portal. 5. As for advertising in the form of seminars, conferences or events: a) At least 02 working days prior to commencement of advertising activities, organizations or individuals that have products, commodities or services under the authority of the Ministry of Health and have obtained the Certificate of approval for advertisement contents from the regulatory agencies affiliated to the Ministry of Health in terms of advertising carried out in the form of seminars, conferences or events must send a written notification of the advertising form, time and location along with the duplicate of the certificate of approval for advertisement contents, sample advertisements or layouts approved by the Department of Health of the place where advertising activities take place in order for them to carry out their inspection and examination whenever necessary; b) In case there is any change made to the location, time of seminars, conferences or events in comparison with the contents specified on the Certificate of approval for advertisement contents, these organizations or individuals must notify the Department of Health located at the area where these events are held at least 02 working days prior to commencement of advertising activities. 6. Procedures for applying for grant of approval for advertisement contents must be repeated from the first steps under the following circumstances: a) The applicant for approval for advertisement contents that corrects or improves their application upon the written request for improvement or correction of this application sent by the receiving authority; b) The applicant for approval for advertisement contents that fail to correct or improve their application by the deadline as stipulated in Clause 2 of this Article. 7. Any organization or individual committing violations against the law on advertising shall be subjected to the competent authority’s refusal to continue to receive their application for approval for advertisement contents until the decision on sanction against such violations has been granted and the violating organization or individual has managed to take action according to this decision. Article 21. Reissuance of the certificate of approval for advertisement contents 1. The damaged or lost certificate of approval for advertisement contents shall be reissued under the following circumstances: a) The organization that signs their name on the Certificate of approval for advertisement contents, or the authorized organization in accordance with regulations, shall send the written request for this reissuance to the competent authority that issued the previous certificate according to the form recommended in the Appendix 04 enclosed herewith; b) Within 05 working days from receipt of the written request based on the date stamp affixed to incoming documents at the receiving authority, the competent authority for approval for advertisement contents shall consider reissuing the certificate of approval for advertisement contents to the applicant. In case of refusing to reissue the Certificate of approval for advertisement contents, the competent authority shall respond to the applicant to clearly state the reasons for such refusal. 2. Reissuance of the certificate of approval for advertisement contents shall be permitted if the validity period of that certificate ends as stipulated in Point a Clause 1, Point a Clause 2, Point a Clause 3, Point a Clause 4 and Point a Clause 5 of Article 23 hereof and the advertisement contents shall remain unchanged as follows: a) The organization that signs their name on the Certificate of approval for advertisement contents, or the authorized organization in accordance with regulations, shall send their application for this reissuance to the competent authority that issued the previous certificate, including the following documents: - Application form for reissuance of the certificate of approval for advertisement contents by completing the form recommended in the Appendix 04 enclosed herewith; - One of the valid documents relevant to products, commodities or services for which advertisement contents are requested to be approved as follows: + As for pharmaceutical advertisement: The certificate of free circulation for products issued by the Drug Administration of Vietnam and the decision on issuance of the pharmaceutical registration numbers granted by this Administration; + As for cosmetic advertisement: the notification of cosmetic products issued by competent authorities; + As for advertising of food or food additive products: the Certificate of Declaration of conformity or Certificate of Declaration of conformity with the food safety regulations (applicable to products on which the technical regulations have not been set yet) issued by regulatory authorities; the description of details about products; samples of main labels approved by competent authorities; + As for advertising of chemicals, insecticides, disinfectants or sanitizers used in household appliance and healthcare industry: the certificate of free circulation for chemicals, insecticides and fertilizers; + As for advertising of medical equipment: the permit for import of medical equipment or the registration certificate of free circulation for medical equipment. - The expired certificate of approval for advertisement contents along with the approved advertisement sample or layout. b) Within 05 working days from receipt of the written request based on the date stamp affixed to incoming documents at the receiving authority, the competent authority for approval for advertisement contents shall consider reissuing the certificate of approval for advertisement contents to the applicant. In case of refusing to reissue the Certificate of approval for advertisement contents, the competent authority should send a written notification in which the reasons for such refusal must be clearly stated. 3. Reissuance of the certificate of approval for advertisement contents shall be permitted if the validity period of that certificate still remains but there is a change made to the name, address of the organization or individual that takes responsibility to launch their products, commodities or services to the market, and the advertisement contents remain unchanged as follows: a) The organization that signs their name on the Certificate of approval for advertisement contents, or the authorized organization in accordance with regulations, shall send their application for this reissuance to the competent authority that issued the previous certificate, including the following documents: - Application form for reissuance of the certificate of approval for advertisement contents by completing the form recommended in the Appendix 04 enclosed herewith; - The preexisting certificate of approval for advertisement contents along with the approved advertisement sample or layout; - The document of the competent authority stating the change made to the name, address of the organization or individual that takes responsibility to launch their products, commodities or services to the market. b) Procedure for reissuance of the certificate of approval for advertisement contents shall be governed under the provisions of Clause 2, 3, 4, 5 Article 20 hereof. 4. Reissuance of the certificate of approval for advertisement contents shall be permitted if the validity period of that certificate ends as stipulated in Article 23 hereof but it does not fall into the case stipulated in Clause 2 of this Article and the case in which the advertisement contents are changed or amended but it does not fall into the case stipulated in Clause 3 of this Article as well: The enterprise must go through procedures for application for approval for advertisement contents which are the same as the initial application. 5. Application for reissuance of the certificate of approval for advertisement contents must conform to requirements stipulated in Clause 3 Article 13 hereof. Article 22. Method of numbering the certificate of approval for advertisement contents 1. As for advertisement contents subject to the certificate of approval for advertisement contents issued by competent agencies affiliated to the Ministry of Health, the numbering shall adhere to the principle as follows: the ordinal numbers/issuance year/XNQC- the shortened name of the issuer. Example: 123/2015/XNQC-ATTP. 2. As for the certificate of approval for advertisement contents issued by the Department of Health, and Food Safety and Hygiene Subdepartment, the numbering shall adhere to the principle as follows: the ordinal numbers/issuance year/XNQC- the shortened name of the issuer and the shortened name of a centrally-affiliated city and province. Example: 123/2015/XNQC-YTHN or 123/2015/XNQC-ATTPHN. Article 23. Circumstances under which the validity of the certificate of approval for advertisement contents is terminated 1. Circumstances under which the validity of the certificate of approval for advertisement contents is terminated a) Pharmaceutical products have the expired registration numbers; b) Pharmaceutical products have suspended registration numbers, or pharmaceutical products are subject to the warning of restricted use given by regulatory authorities; c) Change has been made to information about indications, contraindications or administration dosage. 2. Circumstances under which the validity of the certificate of approval for advertisement contents for cosmetic products is terminated: a) The receiving numbers of the notification of cosmetic products has expired; b) Cosmetic products subject to suspension of free circulation or revocation or recall of the receiving numbers of the notification of products; c) There is any change made to information affecting the safety and quality of cosmetic products. 3. Circumstances under which the validity of the certificate of approval for advertisement contents for foods, food additives, baby milk and nutritional products: a) The Certificate of Declaration of Conformity or Certificate of Declaration of conformity with the food safety regulations has been expired; b) The enterprise is subject to revocation of the certificate of conformity with food safety and hygiene requirements; c) Products or commodities are subject to change to ingredients or useful effects; d) Products or commodities are subject to suspension of free circulation, or are recalled. 4. Circumstances under which the Certificate of approval for contents of advertisements for chemicals, insecticides, disinfectants or sanitizers used in household appliance and health care industry is expired: a) The registration Certificate of free circulation for chemicals, insecticides and fertilizers used in household appliance and healthcare industry has expired; b) Products or commodities are subject to suspension of free circulation, or are recalled; c) Products or commodities have been changed or amended in terms of their ingredients, useful effects or other information causing impacts on the product safety in comparison with information about products or commodities specified in the valid registration certificate of free circulation issued by the Ministry of Health. 5. Circumstances under which the validity of the certificate of approval for medical equipment is terminated: a) The import permit or the registration certificate of free circulation for products or commodities has expired; b) Products or commodities are subject to suspension of free circulation, or are recalled. 6. Circumstances under which the validity of the certificate of approval for advertisement contents for healthcare services is terminated: a) Healthcare establishments are subject to revocation of the permit for operations, their operations are suspended; b) Healthcare establishments have been deprived of the ownership of the permit for operations in accordance with legal regulations on penalties for administrative violations; c) Healthcare establishments have been reissued the permit for operations due to change to their scope of professional operations in relation to healthcare services allowed to be advertised. 7. Other circumstances in accordance with legal regulations. Chapter III IMPLEMENTARY PROVISIONS Article 24. Effect 1. This Circular shall come into force from July 16, 2015. 2. From the effective date of this Circular, the following documents or regulations shall be abolished: a) Regulations on advertising of pharmaceutical products enshrined in the Circular No. 13/2009/TT-BYT of the Minister of Health dated September 1, 2009 on providing guidance on pharmaceutical product communication and advertising operations; b) Regulations on pharmaceutical advertising enshrined in the Circular No. 45/2011/TT-BYT of the Minister of Health dated December 21, 2011 on amendments to several articles of the Decision No. 1570/2000/QĐ-BYT of the Minister of Health dated May 22, 2000 on application of the good laboratory practices; the Decision No. 2701/2001/QĐ-BYT of the Minister of Health dated June 29, 2001 on application of the good storage practices; the Circular No. 06/2004/TT-BYT of the Ministry of Health dated May 28, 2004 on providing guidance on pharmaceutical contract manufacturing; the Decision No. 3886/2004/QĐ-BYT of the Ministry of Health dated November 13, 2004 on application of the good manufacturing practices in conformity with the warning issued by the World Health Organization; the Circular No. 13/2009/TT-BYT of the Ministry of Health dated September 1, 2009 on providing guidance on pharmaceutical communication and advertising operations; the Circular No. 22/2009/TT-BYT of the Ministry of Health dated November 24, 2009 on stipulating the pharmaceutical registration; the Circular No. 47/2010/TT-BYT dated December 29, 2010 on providing guidance on export or import of pharmaceutical products and packages in physical contact with pharmaceutical products; c) The Circular No. 42/2010/TT-BYT of the Ministry of Health dated December 15, 2010 on promulgating the List of medicinal active ingredients and herbal ingredients permitted to be advertised through radio or television programs; d) Regulations on advertising of cosmetic products enshrined in the Circular No. 06/2011/TT-BYT of the Minister of Health dated January 25, 2011 on providing regulations on cosmetic product administration; dd) The Circular No. 08/2013/TT-BYT of the Minister of Health dated March 13, 2013 on providing guidance on advertising of food products under the authority of the Ministry of Health; Article 25. Terms of reference 1. Where documents used as references in this Circular have been amended, replaced or abolished, newly- adopted documents shall be applied. 2. Where documents such as certificates, licenses, notifications and decisions on issuance of the pharmaceutical registration number stipulated in this Circular are subject to amendment or replacement or change of document title stipulated in the competent authority’s legal documents, newly-adopted documents shall be applied. Article 26. Transition provisions 1. Organizations or individuals that have filed their applications for permission for advertising of special products, commodities or services under the authority of the Ministry of Health shall obtain the notice of receipt of applications for permission for advertising from regulatory authorities before the effective date of this Circular shall be allowed to continue their advertising activities until the validity of notice of receipt ends. 2. As for products, commodities or services that meet requirement for issuance of the certificate of approval for Internet-based advertisement contents in the form of online public services, competent authorities shall issue that certificate on the basis of regulations laid down in this Circular and other relevant laws. Article 27. Responsibility for implementation 1. The Heads of competent authorities for issuance of the certificate of approval for advertisement contents as prescribed in Article 12 hereof shall be responsible for performing their assigned tasks according to this Circular, and carrying out examination and supervision of advertising activities after issuance of that certificate is completed. 2. The applicants for approval for advertisement contents shall assume responsibility for legitimacy and accuracy of information and materials provided in their applications and advertisement contents. 3. The Director of the Department of Legal Affairs, the Chief of the Ministry Office, the Chief Inspector of the Ministry, the Department’s Director, the Administration’s Director, the General Director of Departments, Administrations or General Departments affiliated to the Ministry of Health, the Director of the Department of Health, the Director of the Food Safety Subdepartment in a centrally-affiliated city or province as well as other relevant organization or individual, shall take responsibility to implement this Circular. In the course of implementation, if there is any difficulty that may arise, agencies, organizations or individuals concerned should report to the Ministry of Health for to conduct further study and recommend possible solutions./.

PP. THE MINISTER THE DEPUTY MINISTER

Pham Le Tuan

APPENDIX 01 APPLICATION FORM FOR APPROVAL FOR ADVERTISEMENT CONTENTS (Issued together with the Circular No /2015/TT-BYT of the Minister of Health dated ……….., 2015 on the approval for contents of advertisements for special products, commodities and services under the authority of the Ministry of Health) NAME OF THE APPLICANT THE SOCIALIST REPUBLIC OF VIETNAM Independence - Freedom - Happiness ------

No.: /Abbreviated name of the ……(1)……, ………. 20…. applicant

APPLICATION Approval for advertisement contents Dear (2)……………………………, 1. Contact information about the applicant: ...... 1.1. The applicant's name: ...... 1.2. Address: (3)...... Telephone number: ...... Fax: ...... Applies for issuance of approval for advertisement contents for………………………….:

No. Description of Numerical code of the Certificate of free circulation for product, or the product, commodity Decision on issuance of the registration number of pharmaceutical product/ or service (specifying Notification of cosmetic product/ Certificate of Declaration of conformity with type, ....(if any)) the food safety regulations or Certificate of Declaration of Conformity/ Certificate of free circulation for chemicals, insecticides, fertilizers used in household appliance and healthcare industry/ Permit for import of medical equipment or Certificate of free circulation for medical equipment/ Permit for healthcare service operations and the Decision on approval for the list of professional practices

Means of advertising: (If verbal, pictorial or printing press are used for advertising, please specify the specific title of such press; If seminars, conferences or events are used for advertising, please specify proposed schedule and venue) …………………………………………………………………………………………… …………………………………………………………………………………………… Application including the following documents or materials: …………………………………………………………………………………………… …………………………………………………………………………………………… I herein undertake all information and documentation mentioned above are genuine and I am committed to advertising product, commodity or service under the authority of the Ministry of Health in accordance with the approved contents. I am looking forward to your consideration and issuance of approval for the advertisement content./.

The Director or Legal representative Signature (full name, designation and seal)

APPENDIX 02 LIST OF PHARMACEUTICAL ACTIVE INGREDIENTS AND HERBAL MATERIALS REGISTERED FOR PERMISSION TO BE ADVERTISED ON VERBAL OR PICTORIAL PRESS (Issued together with the Circular No /2015/TT-BYT of the Minister of Health dated ……….., 2015 on the approval for contents of advertisements for special products, commodities and services under the authority of the Ministry of Health) 1. CHEMICALLY SYNTHESIZED PHARMACEUTICALS Administration, dosage form, Other specific No. Active ingredients limited content or provisions concentration 1 Acetylcysteine Oral administration: all forms 2 Acetylleucine Oral administration: all forms Single acetylsalicylic acid (Aspirin) used singly Medication for pain or in combination with Vitamin C and/or Citric 3 Oral administration: all forms or fever relief, anti- Acid and/or Sodium bicarbonate and/or Sodium inflammation Salicylate Alginic acid (Sodium alginate) used singly or in 4 combination with aluminum or magnesium Oral administration: all forms compounds Medication for amino Single or compound amino acid (including 5 Oral administration: all forms acid supplement to amino acid combined with Vitamins) human body 6 Aminobenzoic acid (para-aminobenzoic acid) Oral administration: all forms Topical administration 7 Pure or compound Benzoic acid Oral administration: lozenge Topical administration 8 Single or compound Boric acid Eye drop 9 Citric acid combined with sodium or potassium Oral administration: all forms Eye, nasal drop with limited 10 Cromoglicic acid and cromoglicat of all types concentration calculated by Cromoglicic acid ≤ 2% 11 Dimecrotic acid Oral administration: all forms Folic acid used singly or in combination with Medication for anti- 12 iron and/or B-group Vitamins, minerals or Oral administration: all forms anaemia, nutritional Sorbitol supplement Glycyrrhizic acid (Glycyrrhizinat) combined Oral administration: all forms, with other active ingredients such as 13 including lozenge Chlorpheniramine Maleate, Dl-methylephedrine Topical administration and caffeine, etc. 14 Single or compound Lactic acid Topical administration 15 Mefenamic acid Oral administration: all forms Salicylic acid used singly or in combination with topical pharmaceutical products (in 16 Topical administration combination with lactic acid; precipitate phosphorus, etc.) Anti-worm 17 Albendazol Oral administration: all forms medication Dichlorobenzyl alcohol used in combination 18 Oral administration: lozenges and contained in lozenges 19 Polyvinyl alcohol Topical administration 20 Alimemazin tartrat (Trimeprazin tartrat) Oral administration: all forms Allantoin used in combination and contained in Topical administration 21 topical or rectal suppository pharmaceuticals Suppositories (cepae fluid extracts, etc.) Allantoin used in combination with Vitamins 22 Eye drop and/or Chondroitin 23 Almagate Oral administration: all forms Oral administration: all forms with limited active ingredients as follows: Ambroxol used singly or in combination with - Ambroxol clorhydrate with 24 cough suppressants, fever or pain relief dose unit measurement ≤ medicines 30mg/unit - Ambroxol clorhydrate without dose unit measurement ≤ 0.8% Amylase used singly or in combination with 25 Oral administration: all forms protease and/or lipase and/or cellulase Amylmetacresol used in combination and 26 contained in lozenges (like essential oil or Oral administration: lozenges Bacitracin, etc.) Eye drop 27 Argyron Topical administration 28 Aspartame Oral administration: all forms 29 Single or compound Aspartat Oral administration: all forms 30 Attapulgite Oral administration: all forms 31 Azelastin Eye, nasal drop 32 Silver sulfadiazine Topical administration Bacitracin combined with several other active ingredients in lozenges (combined with 33 Oral administration: lozenges Neomycin Sulfate, Amylocaine, Tixocortol, etc.) Benzalkonium used in combination in topical medicines (with choline, salicylic acid, Nystatin Topical administration 34 and Diiodohydroxyquin, etc.), or in lozenges Lozenges (with Tyrothricin, Bacitracin and essential oil, etc.) Topical administration all forms with limited benzocaine ≤ 10%; 35 Compound benzocaine Rectal suppositories Oral administration: lozenges Topical administration all forms Benzoyl peroxide used singly or combined with 36 with limited concentration ≤ Iodine and/or phosphorus 10% Topical administration: oral Benzydamine hydrochloride used singly or in mucosal gel, mouth rinse, 37 combination oromuscosal spray Oral administration: lozenges Benzydamine salicylate used singly or in 38 Topical administration combination Compound benzyl benzoate contained in topical Topical administration; all forms 39 ingredients (combined with essential oil, Patches isopropyl alcohol, etc.) 40 Berberine Oral administration: all forms Biclotymol used singly or in combination with Topical administration 41 Enoxolone and/or Phenylephrine HCl and/or Nasal drop Clorpheniramin maleat and/or essential oil Oral administration: lozenges 42 Bifonazole used singly or combined with Urea Topical administration Oral administration: measured 43 Bisacodyl unit dose with content ≤ 10mg/unit 44 Bismuth salts Oral administration: all forms 45 Boldin Oral administration: all forms 46 Bromelain used singly or combined with trysin Oral administration: all forms Oral administration: all forms with a restricted amount of Bromhexin HCl as follows: Bromhexin HCl used singly or in combination - With measured dosage ≤ 47 in expectorants, fever or pain relief medicines 8mg/unit - Without measured dosage ≤ 0.8% Rectal suppository Brompheniramine maleates used singly or in 48 combination in expectorants, fever or pain relief Oral administration: all forms medicines Bufexamac used singly or in combination in topical, rectal suppository medicines (with Topical administration 49 Titanium dioxide, Bismuth, Subgallate, Rectal suppositories Lidocaine, etc.) 50 Butoconazol Topical administration 51 Caffeine (combined with paracetamol) Oral administration: all forms Calamine used singly or in combination in 52 Topical administration topical medicines Calcium (including compound forms) used Medication for 53 singly or in combination with Vitamin D Oral administration: all forms calcium supplement (Calcitriol) and/or Vitamins and/or Ipriflavone to human body Carbinoxamine used singly or in combination in 54 expectorants, fever or pain relief medicines Oral administration (with Bromhexine and/or Paracetamol) 55 Carbocysteine Oral administration: all forms 56 Carbomer Topical administration Eye drop Catalase used singly or in combination in 57 Topical administration topical medicines (with Neomycin) 58 Cetirizine dihydrocloride Oral administration: all forms Cetrimide used in combination in topical 59 medicines (Lidocaine, zinc, Calamine, Topical administration Aminacrine, essential oil, etc.) Cetrimonium compounds used in topical Topical administration 60 medicines, lozenges (combined with Lidocaine; Oral administration: lozenges Tyrothricin, essential oil, etc.) 61 Chitosan (Polyglusam) Topical administration Choline used singly or in combination with amino acids, Vitamins in medicines Oral administration: all forms 62 administered orally; in combination with Topical administration salicylic acids, Benzalkonium, etc. in topical pharmaceuticals Chondroitin used singly or in combination with 63 Glucosamine and/or fish oil and/or vitamins Oral administration: all forms and/or amino acids Chondroitin used singly or in combination with Eye drop 64 Borneol and/or Vitamins Topical administration 65 Ciclopirox olamine Topical administration 66 Cinnarizine Oral administration: all forms Cinchocaine used singly or in combination in Topical administration 67 topical, rectal suppository medicines (with Rectal suppositories Hydrocortisone, Neomycin, Aesculin, etc.) 68 Citrulline Oral administration: all forms 69 Chlorhexidine Topical administration 70 Chlorophyll Oral administration: all forms Oral administration: all forms Clorpheniramine maleate used singly or in Metered-dosage single form: 71 combination in expectorants, fever or pain relief Clorpheniramine maleate ≤ medicines 4mg/unit. Clorpheniramine maleate combined with 72 Eye drop Chondroitin and/or Vitamins Oral administration: all forms 73 Clotrimazol with limited concentration ≤ 3% Vaginal suppositories Coenzyme Q10 used singly or combined with 74 Oral administration: all forms Vitamins 75 Crotamiton Topical administration Dequalinium used singly or compounds Topical administration contained in topical medicines or lozenges 76 Vaginal suppositories (Tyrothricin; Hydrocortisone; glycyrrhetinic Oral administration: lozenges acid; Lidocaine, etc.) Oral administration: all forms 77 Desloratadine with limited content ≤ 5mg/metered-dosage unit Dexbrompheniramine maleate used singly or 78 Oral administration: all forms compounds contained in expectorants, fever or pain relief medicines Dexclorpheniramine maleate used singly or in 79 combination in expectorants, fever or pain relief Oral administration: all forms medicines Oral administration: all forms 80 Dexibuprofen with limited content ≤ 400mg/metered-dosage unit. Eye drop 81 Dexpanthenol Topical administration Diclofenac used singly or combined with Topical administration 82 Methyl salicylate; essential oil-based Eye drop (single) ingredients, etc. 83 Dicyclomine Oral administration: all forms 84 Diethylphtalate (DEP) Topical administration 85 Dimenhydrinate Oral administration: all forms Dimethicone (Dimethylpolysiloxane) used 86 Oral administration: all forms singly or combined with Guaiazulene Dimethicone compound contained in topical 87 Topical administration medicines (with zinc, calamine, cetrimide, etc.) Oral administration: all forms 88 Dimethindene Topical administration 89 Disodium inosine monophosphate Eye drop 90 Diosmectite (Dioctahedral smectite) Oral administration: all forms Diosmin combined with Hesperidin and/or 91 Oral administration: all forms flavonoid-contained herbal extracts Oral administration: all forms with limited content (calculated by the base form) as follows: 92 Diphenhydramine hydrochloride or monocitrate - With measured dosage ≤ 50mg/unit - Without measured dosage ≤ 2.5% Oral administration: all forms with a limited content as follows: 93 Domperidone - With measured dosage ≤ 10mg/unit - Without measured dosage ≤ 0.1% 94 Copper sulfate Topical administration Doxylamine compounds contained in expectorant, fever, pain relief medicines (with 95 Oral administration: all forms Paracetamol, other active ingredients specified in the list of non-prescription medicines Oral administration, limited Econazole used singly or combined with concentration of Hydrocortisone 96 Hydrocortisone calculated in the base form ≤ 0.05% Enoxolone used singly or in combination in Topical administration: skin 97 topical medicines or lozenges cream, oral mucosal cream, mouth rinse Oral administration: lozenges 98 Eprazinone Oral administration: all forms Esdepallethrin compounds contained in topical 99 medicines (with Piperonyl, Spregal, essential Topical administration oil, substances contained in essential oil) Topical administration (sterilization alcohol) 100 Single or compound Ethanol Oral administration: compound form 101 Etofenamate Topical administration 102 Fenticonazole Topical administration 103 Fexofenadine Oral administration: all forms Lozenges 104 Flurbiprofen Topical administration Eye drop Glucosamine used singly or in combination 105 Oral administration: all forms with Chondroitin and/or Vitamins Medication for sugar Glucose or Dextrose used singly or in 106 Oral administration: all forms or electrolyte combination with Sodium or Potassium supplement. Glycerine used singly or in combination in Topical administration 107 topical medicines, eye drops (with Polysorbate Eye drop 80) 108 Glycerol combined with herbal extracts Rectal suppositories Guaiphenesin used singly or in combination with active ingredients specified in the list of 109 Oral administration: all forms over-the-counter medicines with useful effects of cough suppression, fever and pain relief. Hexamidine used singly or combined with 110 Cetrimide, Lidocaine, Clotrimazole and Topical administration Catalase) Hexetidine used singly or combined with Topical administration: skin 111 Benzydamine, Cetylpyridinium, Choline application cream, mouth rinse Salicylate, Methyl salicylate, essential oil, etc.) Hydrocortisone used singly or combined with Topical administration: all forms 112 Miconazole, Econazole, Tioconazole, with Hydrocortisone Neomycin) concentration ≤ 0.5% Hydrogen peroxide (hydrogen peroxide) used 113 singly or combined with sodium lauryl sulfate Topical administration and/or essential oil 114 Hydrotalcit Oral administration: all forms 115 Hydroxypropyl Methylcellulose (HPMC) Eye drop Oral administration: all forms, Hyoscine (Scopolamine) butylbromid used including chews. 116 singly or in combination with Meclizine Limited content ≤ 20mg/ hydrochloride metered-dosage unit Patches Hypromellose used singly or combined with 117 Eye drop: all forms Dextran 70 and/or Carbomer Oral administration: all forms with limited content ≤ 118 Ibuprofen 400mg/metered-dosage unit. Topical administration 119 Ichthammol Topical administration Iodine combined with Potassium iodide and/or Topical administration: 120 Benzoic Acid and/or Salicylic Acid Concentration ≤ 5% 121 Isoconazol Topical administration 122 Isopropyl Methylphenol Topical administration Zinc oxide, Zinc pyrithione, Zinc Gluconate, 123 Zinc undecylenate used singly or in Topical administration combination in topical medicines Topical administration 124 Zinc sulfate Eye drop Ketoconazole used in singly or combined with Topical administration: all forms 125 Zinc pyrithione and/or Hydrocortisone and/or with Ketoconazole concentration Trolamine ≤ 2% 126 Ketoprofen Topical administration 127 Lactitol Oral administration: all forms 128 Lactoserum atomisate Topical administration 129 Lactulose Oral administration: all forms L-Carnitin used singly or combined with 130 Oral administration: all forms Vitamins 131 Levocetirizine Oral administration: all forms 132 Single or compound Lidocaine Topical administration Lindan (Benhexachlor, 666, Gamma-BHC) Topical administration: Lindan 133 used singly or combined with Lidocaine concentration ≤ 1% Oral administration: all forms with limited content (calculated by the base form) as follows: Loratadine used singly or in combination with 134 - With measured dosage: Paracetamol Loratadins ≤ 10mg/unit; - Without measured dosage: Loratadine ≤ 0.1% 135 Loxoprofen Oral administration: all forms Oral administration: all forms 136 Macrogol Rectal suppositories Magaldrate used singly or combined with 137 Aluminum, Magnesium, Alginic Acid Oral administration: all forms compounds (or Alginate salts). Medication for magnesium supplement to human 138 Magnesium, including its salts or compounds Oral administration: all forms body, gastric acid neutralization or laxativity. 139 Mangiferin Topical administration Oral administration: all forms 140 Mebendazole with a limited content as follows: - With measured dosage ≤ 500mg/unit - Without measured dosage ≤ 2% 141 Fungi enzyme (cellulase fongique) Oral administration: all forms Digestive enzymes used singly or in 142 Oral administration: all forms combination, including vitamins Menthol combined with others such as essential Oral administration: all forms 143 oil complex, Methyl Salycilate, etc. Topical administration: all forms 144 Mequinol Topical administration Oral administration: all forms 145 Mequitazine Topical administration Topical administration: Package 146 Mercurocrome (Antiseptic solution) size ≤ 30ml Methyl salicylate compounds contained in Topical administration 147 lozenges, topical medicines (combined with Patches essential oil, etc.) Lozenges 148 Metronidazole Topical administration Topical administration 149 Miconazole Vaginal cream ≤ 2% Topical administration Vaginal cream with Miconazole 150 Miconazole combined with Hydrocortisone content ≤2%; Hydrocortisone content ≤0.05% Topical administration: all forms 151 Minoxidil with content ≤ ≤5% 152 Mupirocin Topical administration Myrtol used singly or compound contained in Oral administration: all forms 153 lozenges Topical administration Oral administration: all metered- 154 Naproxen dosage forms with limited content ≤ 275mg/unit 155 Single or compound Sodium benzoate Oral administration: all forms 156 Single or compound Sodium bicarbonate Oral administration: all forms 157 Single or compound Sodium carbonate Oral administration: all forms 158 Sodium Carboxymethylcellulose (Na CMC) Eye drop Oral administration: all forms Sodium chloride used singly or in combination Topical administration 159 with potassium citrate, sodium citrate, etc. Eye or nasal drop with concentration 0.9% 160 Ducosate sodium Oral administration: all forms Topical administration: teeth 161 Sodium fluoride compound cleaning or mouth rinse 162 Sodium hyaluronate (Hyaluronic acid) Topical administration Topical administration, 163 Sodium Monofluorophosphate including oromucosal cleaning Oral administration: compound 164 Sodium Salicylate compound form contained in lozenges Topical administration 165 Neomycin sulfate compound contained in Oral administration: lozenges lozenges (zinc; Bacitracin; Amylocaine, etc.), Topical administration topical medicines Dietary elements: Chromium, copper, Medication for potassium, magnesium, zinc, etc. used singly or 166 Oral administration: all forms mineral supplement in combination, including those combined with to human body vitamins Medication for Aluminum, magnesium, calcium and aluminum gastric acid 167 compound, magnesium, calcium used singly or Oral administration: all forms neutralization, gastric in combination ulcer or duodenum mobility. Nomahydrated Natri Sulfid + Saccharomyces Oral administration: all forms 168 Cerevisiae Topical administration 169 Single or compound Nystatin Topical administration Oral administration: metered- Medication for gastro 170 Omeprazole dosage forms with content esophageal reflux ≤10mg/unit disease. 171 Ossein hydroxy apatite Oral administration: all forms 172 Oxeladin Oral administration: all forms 173 Oxomemazine Oral administration: all forms Nasal drop with concentration 174 Oxymetazoline 0.5% Pancreatin used singly or in combination with 175 Simethicone and/or digestive enzymes and/or Oral administration: all forms Group-B vitamins and/or Azintamide Topical administration 176 Panthenol Eye drop Oral administration: all forms Compound form 177 Single paracetamol Rectal suppository stipulated in the List Paracetamol combined with active ingredients specified in this List with useful effects of 178 Oral administration: all forms cough suppression, fever, pain relief and anti- inflammation 179 Pentoxyverin Oral administration: all forms Eye or nasal drop with 180 Phenylephrine HCl concentration ≤ 1% Phenylephrine HCl used in combination in 181 topical medicines (such as Petrolatum sperti Topical administration yellow; Mineral oil light; Shark liver oil...) Phenylephrine HCl used in combination in Oral administration: all forms 182 cough suppressant, fever and pain relief Rectal suppository medicines 183 Phospholipid Oral administration: all forms 184 Picloxydine Eye drop Topical administration: all forms 185 Piroxicam with content ≤ 1% Policresulen (Metacresolsulphonic acid- Topical administration 186 formaldehyd) Rectal suppository Polyethylene glycol 400 used singly or in 187 Eye drop combination with Propylene glycol 188 Polysacharide Oral administration: all forms Polytar used singly or in combination in topical 189 Topical administration medicines (such as Zinc Pyrithione, etc.) Topical administration: all forms 190 Povidone Iodine (including mouth rinse with concentration ≤ 1%). Eye drop Oral administration: all forms with limited content, concentration of Promethazine (calculated by the base form) as Promethazine HCl used singly or in follows: combination in cough suppressant, fever, pain 191 - With measured dosage ≤ relief medicines (with Carbocystein; 12.5mg/unit; Paracetamol, etc.) - Without measured dosage ≤ 0.1% Topical administration: concentration ≤ 2% Medication for worm 192 Pyrantel Oral administration: all forms infection Rutin used singly or in combination with 193 Oral administration: all forms Vitamin C and/or herbal extracts 194 Saccharomyces boulardii Oral administration: all forms Saccharomyces cerevisiae and Magnesium 195 Oral administration: all forms sulfate trihydrate Compound iron in the single active ingredient Medication for iron 196 form or iron combined with vitamin and Oral administration: all forms supplement to human mineral based medicines body Oral administration: all forms Organic selenium used in combination in with limited content as follows: 197 Vitamin, mineral contained medicines - With measured dosage ≤ 50mcg/unit 198 Selenium sulfide Topical administration Silymarin used singly or in combination with 199 Oral administration: all forms Vitamin C and/or herbal extracts. Simethicone used singly or in combination with 200 Pancreatin and/or Desoxycholic Acid and/or Oral administration: all forms Group-B Vitamins and/or digestive enzymes Simethicone combined with aluminum 201 compound, magnesium and/or Dicyclomine Oral administration: all forms and/or activated carbon 202 Single or compound Sorbitol Oral administration: all forms Oral administration: all forms 203 Sterculia (gum sterculia) Rectal suppository 204 Sucralfate Oral administration: all forms 205 Sulbutiamine Oral administration: all forms Sulfogaiacol used singly or in combination in 206 Oral administration: all forms fever, pain relief or cough depression medicines Topical administration: all forms 207 Terbinafine with content ≤ 1% 208 Single terpin Oral administration: all forms 209 Tetrahydrozoline Nasal drop Activated carbon used singly or in combination 210 Oral administration: all forms with Simethicone Oral administration: all forms Essential oil (including Menthol, Pinen, Topical administration: skin 211 Camphor, Cineol, Fenchone, Borneol, Anethol, treatment cream Eucalyptol...) Mouth wash, oromucosal paste Topical administration: all forms Tioconazol used singly or in combination with with concentration as follows 212 Hydrocortisone - Tioconazol ≤ 1.00% - Hydrocortisone ≤ 0.05% 213 Tolnaftate Topical administration Triclosan used singly or in combination with 214 Topical administration topical medicines Triprolidine used singly or in combination in 215 cough suppressants, fever or pain relief Oral administration: all forms medicines Trolamine used singly or in combination in 216 topical medicines (with Triclosan and/or Topical administration Tyrothricin) Tyrothricin used singly or in combination (with Oral administration: lozenges Benzalkonium, Benzocaine, Formaldehyde, Topical administration: 217 Trolamine, essential oil and ingredients mouthwash solution, spray and contained in essential oil) skin cream Urea used singly or in combination with Vitamin E and/or Bifonazole and/or herbal 218 ingredients which are not specified in the List Topical administration of toxic herbal ingredients used for producing pharmaceuticals Oral administration: all forms with limited content of Vitamin Vitamin A and pre-Vitamin A (Betacarotene) 219 A ≤ 5000 IU/unit used singly and in combination with vitamins Topical administration Eye drop Oral administration: all forms Topical administration Single Vitamin (except for single Vitamin D) or Oral compounds containing Medication for compounds containing Vitamins, minerals, 220 Vitamin A with limited content Vitamin, mineral and Amino acids, fatty acids, taurine, lutein and as follows: nutrition supplement Zeaxanthin Vitamin A ≤ 5000 IU/ metered dosage unit Single or compound Group-B vitamin, Vitamin Eye drop 221 PP Bacteria beneficial to digestive health: Bacillus claussi, Bacillus subtilis, Lactobacillus 222 Oral administration: all forms acidophilus in the single or compound form, including those combined with vitamins 223 Methylene blue Topical administration Nasal drop with limited Xylometazoline used singly or in combination 224 concentration of Xylometazoline with Benzalkonium. ≤ 1% 2. ORIENTAL MEDICINES AND HERBAL MEDICINES Oriental or herbal medicines are specified in the List of non-prescription medicines and meet regulations laid down in this Circular.

APPENDIX 03 TEMPLATE OF CERTIFICATE OF APPROVAL FOR ADVERTISEMENT CONTENTS (Issued together with the Circular No /2015/TT-BYT of the Minister of Health dated ……….., 2015 on providing guidance on advertising activities under the authority of the Ministry of Health)

THE MINISTRY OF HEALTH/THE THE SOCIALIST REPUBLIC OF VIETNAM DEPARTMENT OF HEALTH Independence - Freedom - Happiness ………(4)……. ------

No.: /XNQC-…(5)… Name of province/city, ………., 20...

CERTIFICATE OF APPROVAL FOR ADVERTISEMENT CONTENTS Name of organization, individual: ...... Address: ...... Telephone number: ………………………………..Fax:……………………….

No. Description of Numerical code of the Certificate of free circulation for product, or the Decision on product, issuance of the registration number of pharmaceutical product/ Notification of commodity or cosmetic product/ Certificate of Declaration of conformity with the food safety service (specifying regulations or Certificate of Declaration of Conformity/ Certificate of free type, ....(if any)) circulation for chemicals, insecticides, fertilizers used in household appliance and healthcare industry/ Permit for import of medical equipment or Certificate of free circulation for medical equipment/ Permit for healthcare service operations and the Decision on approval for the list of professional practices

Means of advertising: (If verbal, pictorial or printing press are used for advertising, please specify the specific title of such press; If seminars, conferences or events are used for advertising, please specify proposed schedule, venue and presenters) …………………………………………………………………………………………… …………………………………………………………………………………………… Advertisement contents: In conformity with approved attached contents of organization/individual in conformity with applicable regulations. Organization/ individual shall assume responsibility to conform to approved advertisement contents.

Approver (Signature, full name and stamp)

APPENDIX 04 TEMPLATE OF APPLICATION FOR REISSUANCE OF CERTIFICATE OF APPROVAL FOR ADVERTISEMENT CONTENTS (Issued together with the Circular No /2015/TT-BYT of the Minister of Health dated ………..,2015 on providing guidance on approval for contents of advertisements for special products, commodities and services under the authority of the Ministry of Health)

NAME OF THE APPLICANT THE SOCIALIST REPUBLIC OF VIETNAM ------Independence - Freedom - Happiness ------

No.: /Abbreviated name of the (6)…, ……………, 20…. applicant

APPLICATION Reissuance of the certificate of approval for advertisement contents Dear: ...... (7)...... 1. The applicant’s details:……………………………………………………….. 1.1. Name of the applicant:…………………………………………………………. 1.2. Office address: (8)……………………………………………………………...... Telephone number: ………………………………..Fax:………………………. The previous Certificate of approval for advertisement contents:………………….. Issue date:...... Issue place:...... Applies for issuance of the Certificate of approval for advertisement contents for………..

No. Description of Numerical code of the Cerificate of free circulation for product, or the Decision product, commodity on issuance of the registration number of pharmaceutical product/ Notification or service (specifying of cosmetic product/ Certificate of Declaration of conformity with the food type, ....(if any)) safety regulations or Certificate of Declaration of Conformity/ Certificate of free circulation for chemicals, insecticides, fertilizers used in household appliance and healthcare industry/ Permit for import of medical equipment or Certificate of free circulation for medical equipment/ Permit for healthcare service operations and the Decision on approval for the list of professional practices

Means of advertising: (If verbal, pictorial or printing press are used for advertising, please specify the specific title of such press; If seminars, conferences or events are used for advertising, please specify proposed schedule and venue) …………………………………………………………………………………………… …………………………………………………………………………………………… Reasons for application for reissuance of the certificate of approval for advertisement contents: (9)……………… …………………………………………………………………………………………… Application including the following documents or materials: …………………………………………………………………………………………… …………………………………………………………………………………………… I herein undertake all information and documentation mentioned above are genuine and I am committed to advertising product, commodity or service under the authority of the Ministry of Health in accordance with the approved contents. I am looking forward to your consideration and issuance of approval for the advertisement content./.

The Director or Legal representative Signature (full name, designation and seal)

(1) Geographical name (2) The receiving authority: The competent authorities stipulated in Article 12 hereof. (3) Provide the address printed on the certificate of business registration (4) Name of the receiving authority (5) Abbreviation of the authority for approval for advertisement contents (6) Geographical name (7) Name of the issuer of the certificate of approval for advertisement contents (8) Provide the address printed on the certificate of business registration (9) Specify reasons as stipulated in Article 21 hereof.